ClinicalTrials.gg
RecruitingNCT07099846P-005Updated Sep 8, 2025

Hyaluronic Acid and Polynucleotides in Ridge Preservation

An interventional study of regeneration of post extraction socket with biomaterials in Socket Preservation, Implant-supported Single Crowns and Hyaluronic Acid, sponsored by University of Parma. Recruiting at 2 sites in Italy. Open to participants aged 25 Years and older. Per ClinicalTrials.gov, last updated 2025-09-08.

Sponsored by University of Parma · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Jun 2025; still recruiting 1 year 5 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
25 Years and older
Sex
All
01

Study summary

The aim of this study is to test the use of a bovine-derived bone graft combined with a polynucleotides-rich hyaluronic acid (PNHA) gel for the preservation of the bone after a tooth extraction (alveolar ridge preservation) and to test the performance of a fully-digital workflow to rehabilitate the site with a dental implant. 40 patients in need for a single tooth extraction will be recruited at Centro di Odontoiatria, Università di Parma and they will be randomly assigned to 2 groups: extraction and spontaneous healing or extraction and regeneration of the site with a bovine-derived bone graft combined with a PNHA gel. At 4 months after extraction an implant will be placed in the extraction site, which will be rehabilitated with a fully-digital workflow and patients will be followed up at up to 12 months post rehabilitation. Two 3D x-rays with a small field of view will be performed immediately after extraction and at 4 months post extraction to plan implant placement. These images will also be used to assess changes in the dimension of the post extraction bone (primary outcome). As part of the study different questionnaires will be administered to assess quality of life and perception of the therapy and the wound exudate in the area of the extraction will be collected non invasively with a collagen sponge to assess the expression of different proteins during the early healing days. On the day of implant placement a sample of bone tissue will also be collected as part of the bone drilling and histologically analysed.

Read the detailed description

This is a single-centre, double-blind RCT involving 40 patients in need for a single tooth extraction to be replaced with a dental implant. The study consists of 11 visits, over a minimum period of 20 months. Participants will be recruited at Centro di Odontoiatria, at Università di Parma amongst patients routinely seen in new patient clinics and follow-up clinics. After atraumatic tooth extraction, participants will be randomly allocated to one of the following treatment groups: - DBBM (Bio-oss, Geistlich) mixed with a PNHA gel (Regenfast, Mastelli) and socket sealed with a porcine collagen matrix (Mucograft seal, Geistlich) (Test); - Unassisted socket healing (Control). Patient post-operative discomfort will be assessed with a visual analogue scale (VAS) and through clinician-reported post-operative oedema/swelling. Clinical evaluation of socket healing and recording of soft tissue healing index of Landry will also be performed during the early post-extraction days. With the help of a sterilecollagen sponge, wound exudate will be collected at 3, 7 and 14 days post extraction. A CBCT with a small field of view (e.g. 5X8 cm) will be taken to assess the post-extraction socket dimensions and after 4 months to plan implant placement. The CBCT scan will be processed with its embedded segmentation function to remove scattering defects and obtain the maximal possible quality.

Changes in alveolar ridge width from the extraction until 4 months post extraction between the 2 groups will be assessed with a dedicated software (e.g. SMOP) (primary outcome).

On the day of implant placement, a bone core biopsy will be collected from the drilling site. Undecalcified histology analysis will be done, and qualitative histology will be performed by a blind examiner, who will assess the level of maturation of the tissue in the two groups. Moreover, histomorphometric measurements will be recorded and presented descriptively, including amount of mineralized bone, as well as other standard parameters, such as %graft particles (test group only) and % of immature woven bone. A fully digital workflow will be followed to rehabilitate the patients, which will be followed up at up to 12 months post implant loading.

02

Conditions studied

  • Socket Preservation
  • Implant-supported Single Crowns
  • Hyaluronic Acid
  • CAD-CAM

Keywords

  • alveolar ridge preservation
  • hyaluronic acid
  • polynucleotides
  • digital workflow
  • CAD-CAM
  • Implant rehabilitation
03

In context

Lead sponsor

University of Parma is the lead sponsor of 77 studies on the registry; 8 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
25 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • ≥25-year-old males and females;
  • good systemic health (self-assessment);
  • presence of an unrestorable/hopeless tooth with periodontal attachment and buccal bone preserved at least for 2/3rd of the root and not associated with acute periapical pathology;
  • full mouth bleeding and plaque scores ≤ 25%

Exclusion criteria

Exclusion Criteria:

  • uncontrolled or untreated periodontal disease;
  • history of local (head and neck) radiation therapy in the past 5 years;
  • acute endodontic lesion in the test tooth or in the neighbouring areas to the extraction procedure (sites with presence of an asymptomatic chronic lesion are eligible);
  • medical history that includes uncontrolled diabetes or hepatic or renal disease, or other serious medical conditions that can impact on bone metabolism (e.g. rheumatoid arthritis, osteoporosis) or transmittable diseases (e.g. -related disease);
  • history of alcohol or drug abuse;
  • smokers of ≥10 cigarettes a day;
  • self-reported pregnancy or lactation.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

HIV

The human immunodeficiency virus, which weakens the immune system.

Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
40 participants (estimated)

Study arms

  • No intervention
    Spontaneous post extraction healing

    The control group will not receive any biomaterial in the post extraction socket

  • Experimental
    Alveolar ridge preservation

    In the group assigned to receive socket preservation, particulate deproteinizied bovine bone mineral (Bio-oss, Geistlich biomaterials) mixed with a gel containing hyaluronic acid and polynucleotides (Regenfast, Mastelli) will be placed in the socket without overfilling it and the socket will be sealed with a porcine collagen matrix (Mucograft seal, Geistlich), Any remaining PNHA gel will be placed at the entrance of the socket and on the surrounding gingival tissue

    Device: regeneration of post extraction socket with biomaterials

Interventions

  • Deviceregeneration of post extraction socket with biomaterials

    after tooth extraction, in the test group we will place a demineralised bovine bone graft mixed with a gel containing hyaluronic acid and polynucleotide and we will cover the entrance of the socket with a collagen matrix

    Also known as: alveolar ridge preservation, socket preservation

06

What researchers measure

Primary outcomes

  1. Change in alveolar ridge width at 4 months post extraction between study groups

    This is a superiority outcome evaluating horizontal ridge width changes at four months post-extraction between test and contro group with the help of a CBCT scan.

    Time frame: 4 months after tooth extraction (visit 6)

Secondary outcomes

  1. quality of newly formed bone

    to qualitatively assess socket healing and the maturity of the newly formed bone when DBBM combined with a PNHA and covered by a collagen matrix is employed for alveolar ridge preservation as compared to unassisted healing . A bone core biopsy will be taken at 4 months in both groups and the percentage of connective tissue, woven bone and mineralised bone calculated

    Time frame: 4 months post extraction (visit 6)

  2. 3D volume changes

    to assess 3D volume changes in soft and hard tissues at 4 and 12 months post extraction (this will be performed after digitally superimposing DICOM and STL files and in a selected region of interest) in the test and control groups

    Time frame: 4 months post extraction (visit 6)

  3. changes in protein expression

    to assess and compare the expression of proteins and signalling pathways in the wound exudate at early healing stages. This will be done through full proteomic analysis via mass spectrometry of the wound exudate

    Time frame: 3, 7 and 14 days post extraction (Visit 3, 4, 5)

  4. Profilometric changes

    to assess profilometric changes in the alveolar ridge via superimposition of intra oral scans of test and control groups

    Time frame: 3, 7, 14 days and at 4 months post extraction (visit 3, 4, 5)

  5. Change in post operative discomfort

    to assess changes in patient post-operative discomfort, interference with daily activities and oedema and clinician-reported post-operative oedema/swelling via visual analogue scale (VAS) scale going from 0 (no effect) to 10 (maximum negative effect)

    Time frame: 3, 7 and 14 days after extraction (visit 3, 4, 5)

  6. Change in Landry healing index

    to assess changes in soft tissue healing index of Landry (qualitative index measured with a visual scale) in the test and control groups

    Time frame: 3, 7 and 14 days after extraction (Visit 3, 4, 5)

  7. Changes in keratinized tissue

    to assess changes in keratinized tissue (KT) height (measured in mm) in the area of the extraction (with the help of a periodontal probe) in the test and control groups

    Time frame: 4 months post extraction (Visit 6) and at study termination 12 months post loading (Visit 10);

  8. Qualitative assessment of post-operative need for medications

    To record self-reported dosage and type of medications taken by the patients to control post operative pain in the test and control groups

    Time frame: Starting after extraction (visit 2) and until 14 days post extraction (Visit 3, 4, 5)

  9. Possibility to prosthetically place an implant

    To qualitatively describe the ability or not to place the implant in a prosthetically guided implant position with the endosteal portion of the implant completely in bone with more than 1-1.5 mm thickness on the buccal and oral aspect (Tonetti et al., 2023) (i.e. need for regeneration) at implant placement

    Time frame: implant placement (Visit 7 - within 5 months from tooth extraction)

  10. Peri-implant radiographic bone level changes

    To assess on peri-apical x-rays the changes in peri-implant bone levels (distance between bone crest and implant shoulder) in the 2 groups

    Time frame: at implant loading (visit 9 - within 5 months from implant placement) and at the end of the study (12 months post loading - visit 10)

  11. Participants' satisfaction with treatment

    To qualitatively report participants' satisfaction via visual analogue scale (VAS) scale going from 0 (worse) to 10 (maximum positive effect)

    Time frame: at the end of the study, 12 months post loading (Visit 10)

  12. Implant torque

    To qualitatively report implant torque, which is assessed with a torque wrench after surgically placing the implant and is measured in N/cm

    Time frame: Implant placement (visit 7 - within 5 months from tooth extraction)

07

Study locations

2 of 2 sites recruiting
  • Centro di Odontoiatria, Dipartimento di Medicina e Chirurgia, Università di Parma
    Parma, 43126, Italy
    Recruiting
    • Elena Calciolari, DDS, MS, PhD · Contactelena.calciolari@unipr.it · +390521903640
    • Elena Calciolari, DDS, MS, PhD · Principal investigator
  • Centro di Odontoiatria
    Parma, 43126, Italy
    Recruiting
    • Elena Calciolari, DDS, MS, PhD · Contactelena.calciolari@unipr.it · 0521903640
    • Federico Rivara, DDS, MS, PhD · Sub investigator
08

References and documents

Publications

  • Guizzardi S, Galli C, Govoni P, Boratto R, Cattarini G, Martini D, Belletti S, Scandroglio R. Polydeoxyribonucleotide (PDRN) promotes human osteoblast proliferation: a new proposal for bone tissue repair. Life Sci. 2003 Aug 29;73(15):1973-83. doi: 10.1016/s0024-3205(03)00547-2. PubMed 12899922 ↗
  • Colangelo MT, Govoni P, Belletti S, Squadrito F, Guizzardi S, Galli C. Polynucleotide biogel enhances tissue repair, matrix deposition and organization. J Biol Regul Homeost Agents. 2021 Jan-Feb;35(1):355-362. doi: 10.23812/20-320-L. No abstract available. PubMed 33480222 ↗
  • Avila-Ortiz G, Chambrone L, Vignoletti F. Effect of alveolar ridge preservation interventions following tooth extraction: A systematic review and meta-analysis. J Clin Periodontol. 2019 Jun;46 Suppl 21:195-223. doi: 10.1111/jcpe.13057. PubMed 30623987 ↗

Individual participant data

Plan to share: No — All patients' data held will be coded and pseudo-anonymised with an alphanumerical code that will be kept separately from the personal data as name, surname, date and place of birth and sex and stored in a locked cabinet in the PI's office. The only people within the Centro di Odontoiatria who will have access to information that identifies the patients will be people who need to contact them about the research study, and make sure that relevant information about the study is recorded for their care, and to oversee the quality of the study or audit the data collection process. The people who analyse the information will not be able to identify patients and will not be able to find out their name or contact details.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jun 2025 (actual). Primary completion is estimated for Mar 2028, 33 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
May 8, 2025
First posted
Aug 1, 2025
StartActual
Jun 9, 2025
Primary completionEst.
Mar 2028
CompletionEst.
May 2028
Last update
Sep 8, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 8, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07099846
Lead sponsor
University of Parma
Collaborators
Geistlich Pharma AG
Responsible party
Sponsor
First posted
Aug 1, 2025
Start date
Jun 9, 2025
Primary completion
Mar 2028 (estimated)
Completion
May 2028 (estimated)
Last update
Sep 8, 2025

Study contacts

Elena Calciolari, DDS, MS, PhD
Contact
elena.calciolari@unipr.it
+390521903640
Federico Rivara, DDS, MS, PhD
Contact
federico.rivara1@unipr.it
+390521903640

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion